TerrAscend (TSNDF) Non-Current Debt (2020 - 2026)

TerrAscend's (TSNDF) quarterly Non-Current Debt came in at $204.9 million in Q1 2026, up 11.83% year-on-year from $183.3 million in Q1 2025, and up 0.53% on a QoQ basis from $203.8 million in Q4 2025.

TerrAscend (TSNDF) Non-Current Debt (2020 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 7 years of Non-Current Debt data on file, last reported at $204.9 million in Q1 2026.

  • On a quarterly basis, Non-Current Debt rose 11.83% year-over-year to $204.9 million in Q1 2026; TTM through Mar 2026 was $204.9 million, a 11.83% increase from a year earlier, with the FY2025 full-year figure at $203.8 million, up 11.11% from the prior year.
  • Non-Current Debt for Q1 2026 stood at $204.9 million, up from $203.8 million in the prior quarter.
  • Over the last five years, Non-Current Debt for TSNDF reached as high as $211.9 million in Q3 2025 and fell as low as $58.4 million in Q1 2024.
  • Historically, Non-Current Debt has averaged $172.1 million across 5 years, with a median of $183.3 million in 2025.
  • Across the five-year window, Non-Current Debt slumped 70.44% in 2024 and jumped 213.74% in 2025, its largest moves.
  • Year by year, Non-Current Debt stood at $145.9 million in 2022, then slumped by 57.74% to $61.6 million in 2023, then surged by 197.67% to $183.5 million in 2024, then gained by 11.11% to $203.8 million in 2025, then rose by 0.53% to $204.9 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Debt figures were $204.9 million in Q1 2026, $203.8 million in Q4 2025, and $211.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 10.34 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 14.02 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 9.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 27.86 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 12.41 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.74 Bn
10 TerrAscend 160.44 Mn 162.98 Mn 34.60 Mn 204.93 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 204.93 Mn
Dec 31, 2025 203.85 Mn
Sep 30, 2025 211.91 Mn
Jun 30, 2025 199.12 Mn
Mar 31, 2025 183.25 Mn
Dec 31, 2024 183.46 Mn
Sep 30, 2024 182.58 Mn
Jun 30, 2024 171.93 Mn
Mar 31, 2024 58.41 Mn
Dec 31, 2023 61.63 Mn
Sep 30, 2023 203.65 Mn
Jun 30, 2023 180.40 Mn
Mar 31, 2023 197.57 Mn
Dec 31, 2022 145.85 Mn
Sep 30, 2022 172.32 Mn
Jun 30, 2022 180.78 Mn
Mar 31, 2022 184.56 Mn
Dec 31, 2021 179.49 Mn
Dec 31, 2020 171.34 Mn